EZRA Innovations ezrapharma.com


EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical ingredients (API), DSC possesses the ability to change the chemical moiety of existing drugs and better extend release rates.

EZRA Innovations currently holds exclusive worldwide rights in a controlled-release drug delivery system. Drug Surfactant Complex (DSC) Deoxycholate is used in combination with active pharmaceutical ingredients (API), DSC possesses the ability to cha...Show all

Company (Alive / Active)

Phone: 941-323-6577

Fax:

4301 West Markham Street

Little Rock, 72202
Arkansas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EZRA Innovations $7.8M Oct 28, 2016
Pacira Pharmaceuticals $111.3M Apr 13, 2012
The Liposome Company $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EZRA Innovations Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Extended release pharmaceutical formulations with controlled impurity levels Mar 24, 2016 Jun 27, 2017 Patent
Extended release pharmaceutical formulations Mar 24, 2016 Jun 13, 2017 Patent
Extended release pharmaceutical formulations with controlled impurity levels Jun 26, 2017 Application
Extended release pharmaceutical formulations Jun 12, 2017 Application
Method of treating hypertension May 13, 2016 Application
See all 6 patents